Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aida Pharmaceuticals Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aida Pharmaceuticals Inc since year 2005.
Table 2 shows the detailed insider transactions of Aida Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is AIDA. The reporting company's CIK number is 1220286.
The total value of stock buying since 2005 is $6,004.
The total value of stock sales since 2005 is $1,611.
The total value of stock option exercises since 2005 is $0.
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2006-12 | 6,005,037 | $6,004 | 1,611,939 | $1,611 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-12-19 | Jin Baio (CEO, Chairman) | Buy | 5,343,525 | .00 | 5,343 |
| 2006-12-19 | Qiu Jiajun (Director) | Sale | 1,611,939 | .00 | 1,611 |
| 2006-12-19 | Lin Hui (CFO) | Buy | 661,512 | .00 | 661 |
Insider trading activities including stock purchases, stock sales, and option exercises of AIDA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aida Pharmaceuticals Inc (symbol AIDA, CIK number 1220286) see the Securities and Exchange Commission (SEC) website.